Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jr B Kenneth Lee


  • Director at Biocryst Pharmaceuticals Inc (BCRX), 2019-05-31
  • Large Shareholder at Phasebio Pharmaceuticals Inc (PHAS), 2018-10-24
  • Director at Eyenovia Inc. (EYEN), 2018-07-26
  • Large Shareholder at G1 Therapeutics Inc. (GTHX), 2018-06-01
  • Director at Aralez Pharmaceuticals Inc. (ARLZ), 2017-05-13
  • Large Shareholder, Other at Clearside Biomedical Inc. (CLSD), 2017-01-20
  • Director at Pozen Inc (POZN), 2015-06-26
  • Director at Maxygen Inc (MAXY), 2012-06-07
  • Director at Inspire Pharmaceuticals Inc (ISPH), 2011-05-16
  • Director at Osi Pharmaceuticals Inc (OSIP), 2010-06-07
  • Director at Cv Therapeutics Inc (CVTX), 2009-04-03
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ARLZ $2.52 5,000 Director 95,452 2017-03-15 Filing
ARLZ $4.95 1,000 Director 90,452 2016-11-14 Filing
ARLZ $3.50 1,000 Director 83,356 2016-05-13 Filing
MAXY $5.23 3,000 Director 54,000 2011-06-01 Filing
POZN $6.50 1,000 Director 9,000 2010-11-16 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BCRX $12.69 12,665 Director 10,252 2014-03-06 Filing
POZN $6.49 15,871 Director 19,796 2012-09-14 Filing